Gingival hyperplasia associated with amlodipine: case report
DOI:
https://doi.org/10.22491/1983-7550-53-1-O2Keywords:
Gingival hyperplasia, Amlodipine, Gingivoplasty, Dental biofilm, Calcium channel blockers, Arterial hypertensionAbstract
Plaque-induced gingival hyperplasia modified by medication has been associated with certain pharmacological agents, including amlodipine, a dihydropyridine-class antihypertensive. This condition is characterized by excessive gingival overgrowth, which compromises both oral hygiene and aesthetics. The objective of this study was to report the integrated therapeutic approach in the management of severe gingival hyperplasia associated with amlodipine use, following the change of medication by the cardiologist in a male patient, specifying the diagnosis, treatment plan, and clinical outcome. Following the change in medication, the patient exhibited a reduction in gingival hyperplasia, supported by dental biofilm control and supragingival and subgingival scaling. After reevaluation, gingivectomy and gingivoplasty were performed, though to a lesser extent. The patient was advised on the importance of routine oral hygiene for maintaining periodontal health. The case underscores the importance of integrated medical and dental management in effectively reducing gingival hyperplasia and minimizing the extent of surgical intervention. The therapeutic approach—comprising basic periodontal therapy, oral hygiene instruction, and periodontal surgery—resulted in significant clinical improvement, meeting both aesthetic and functional patient needs.
References
1. Caton JG, Armitage G, Berglundh T, Chapple ILC, Jepsen S, Kornman KS, et al. A new classification scheme for periodontal and peri-implant diseases and conditions: introduction and key changes from the 1999 classification. J Periodontol. 2018 Jun;45(Suppl 20):S1-8.
2. Murakami S, Mealey BL, Mariotti A, Chapple ILC. Dental plaque-induced gingival conditions. J Periodontol. 2018 Jun;89(Suppl 1):S17-27.
3. Madi M, Shetty SR, Babu SG, Achalli S. Amlodipine-induced gingival hyperplasia: a case report and review. West Indian Med J. 2015 Jun;64(3):279-82.
4. Lafzi A, Farahani RMZ, Shoja MAM. Amlodipine-induced gingival hyperplasia. Med Oral Patol Oral Cir Bucal. 2006 Nov;11(6):E480-2.
5. Seymour RA, Thomason JM, Ellis JS. The pathogenesis of the drug-induced gingival overgrowth. J Clin Periodontol. 1996 Mar;23(3 Pt 1):165-75.
6. Seymour RA, Ellis JS, Thomason JM. Risk factors for drug-induced gingival overgrowth. J Clin Periodontol. 2000 Apr;27(4):217-23.
7. Camargo PM, Melnick PR, Pirih FQ, Lagos R, Takei HH. Treatment of drug-induced gingival enlargement: aesthetic and functional considerations. Periodontol 2000. 2001;27:131-8.
8. Srivastava AK, Kundu D, Bandyopadhyay P, Pal AK. Management of amlodipine-induced gingival enlargement: series of three cases. J Indian Soc Periodontol. 2010 Oct;14(4):279-81.
9. Hatahira H, Abe J, Hane Y, Matsui T, Sasaoka S, Motooka Y, et al. Drug-induced gingival hyperplasia: a retrospective study using spontaneous reporting system databases. J Pharm Health Care Sci. 2017 Jul;3:19.
10. Goiris FA, D’Agostino M, Rosa MR, Almeida GR, Faria AC, Rosing CK. Amlodipine-induced gingival overgrowth: review and case report. Braz J Dev. 2021;7(7):73532-45.
11. Misra SR, Lakshmi SK, Mohanty N. Amlodipine-induced gingival enlargement. BMJ Case Rep. 2021;14(8):e245098.
12. Bakshi SS, Choudhary M, Agrawal A, Chakole S. Drug-induced gingival hyperplasia in a hypertensive patient: a case report. Cureus. 2023 Feb;15(2):e34558.
13. Livada R, Shiloah J. Calcium channel blocker-induced gingival enlargement. J Hum Hypertens. 2014 Jan;28(1):10-4.
14. Andrade SC, Pires JR, Villacorta CM, Frascaria ADC, Moreira FA, Souza Carvalho AC. Aumento gengival causado por amlodipina de uso crônico: relato de caso clínico. Rev OARF. 2016;1(1):17-27.
15. Pavlic V, Zubovic N, Ilic S, Adamovic T. Untypical amlodipine-induced gingival hyperplasia. Case Rep Dent. 2015;2015:756976.
16. Cekmez F, Pirgon O, Tanju IA. Idiopathic gingival hyperplasia. Int J Biomed Sci. 2009 Jun;5(2):198-200.
17. Lauritano D, Martinelli M, Baj A, Beltramini G, Candotto V, Ruggiero F, et al. Drug-induced gingival hyperplasia: an in vitro study using amlodipine and human gingival fibroblasts. Int J Immunopathol Pharmacol. 2019;33:2058738419876980.
18. Mojsilović J, Jovičić N, Ristić SV, Stevanović M, Mijailović S, Rosić G, et al. Novel insights into amlodipine-induced gingival enlargement: a clinical and molecular perspective. Pharmaceuticals (Basel). 2024;17(8):1075.
19. Pasupuleti MK, Musalaiah SV, Nagasree M, Kumar PA. Combination of inflammatory and amlodipine-induced gingival overgrowth in a patient with cardiovascular disease. Avicenna J Med. 2013 Jul;3(3):68-72.
20. Okumuş OF. Treatment of gingival growth due to amlodipine use with a 445-nm diode laser: a case report. Cureus. 2022;14(12):e32592.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Naval Dental Jounal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
